Timothy C. Barabe - Aug 12, 2024 Form 4 Insider Report for Cartesian Therapeutics, Inc. (RNAC)

Role
Director
Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Timothy C. Barabe
Stock symbol
RNAC
Transactions as of
Aug 12, 2024
Transactions value $
$95,250
Form type
4
Date filed
8/14/2024, 04:41 PM
Previous filing
Jan 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RNAC Common Stock Purchase $95.3K +7.5K +52.57% $12.70 21.8K Aug 12, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RNAC Stock Option (Right to Buy) 7.6K Aug 12, 2024 Common Stock 7.6K $19.66 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On April 4, 2024, the issuer effected a 1-for-30 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 has been adjusted to reflect the Reverse Stock Split.
F2 This award will vest in 36 equal monthly installments, so that it shall be fully vested on the third anniversary of the date of grant.